Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding Study of SVT-40776 (Tarafenacin) in Overactive Bladder
NCT00507169Phase 2Completed
- Sponsor
- Laboratorios Salvat
- Start
- Sep 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tarafenacin in overactive bladder syndrome (OAB), sponsored by Laboratorios Salvat. Started Sep 2006; status: completed.
02
Drugs
tarafenacin
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT00507169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507169.